Startups

Parkview Health

Fort Wayne, Indiana, United States

Parkview Health is a community-owned, nonprofit healthcare system serving Indiana and northwest Ohio. Its 2026 institutional factsheet identifies Parkview Health System Inc., incorporated in May 1995, as a 501(c)(3) organization. Its clinical roots extend to Fort Wayne City Hospital in 1878. The current system leadership directory describes 15 hospitals, more than 1,400 providers and more than 300 locations; the factsheet reports more than 17,500 employees and separately lists hospital facilities. This Indiana institution is distinct from Colorado’s Parkview Medical Center and unrelated investment firms. The Parkview Mirro Center for Research and Innovation supports clinical research, simulation, precision and genomic medicine, health informatics and healthcare technology commercialization. Its Health Services and Informatics Research team brings together data scientists, software engineers, psychologists, epidemiologists, human-computer interaction researchers and clinical project leaders. Projects cover digital health, behavioral and mental health, population health and patient-centered technology. Mirro is an institutional research and innovation center, rather than a separately established venture fund manager. Parkview Health is a named institutional participant in NeuroBell’s June 2026 financing, confirmed by University College Cork. NeuroBell develops neonatal brain-monitoring and AI technology. The announcement identifies Parkview Health in the United States without specifying a contracting subsidiary, investment vehicle or individual ticket. This institutional participation does not establish clinical device approval. The MedTech Global Gateway, operated with the Northeast Indiana Regional Partnership and Indiana Economic Development Corporation, helps international innovators with US market entry, clinical and regulatory connections, product usability and commercialization. Parkview’s Global Innovation Competition and community grants are separate programmes; prize ceilings, potential pilots and grant limits are not private fund closes or evidence of paid equity investments. A December 2025 partnership with Notre Dame and the 1842 Fund aims to create up to two AI businesses addressing rural healthcare in 2026. The announcement attributes initial investment to the external 1842 Fund, powered by Alloy Partners, rather than to a Parkview-owned fund. Published leadership includes the six current system executives, the 23-person Mirro informatics research directory, board chair Dan Starr and community-impact leader Sarah GiaQuinta. Rick Henvey is CEO; Ray Dusman leads the physician and clinical enterprise and serves as board vice chair. Research-team roles are scoped to Mirro and do not imply individual investment authority. Exact private financing allocations, a comprehensive current board roster and any independently managed Parkview venture fund remain unverified.